Variant report
Variant | nsv596257 |
---|---|
Chromosome Location | chr4:175626079-175631711 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000145451 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113322994 | chr4:175626099-175626100 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs202052113 | chr4:175626103-175626104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7658261 | chr4:175626104-175626105 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs78290680 | chr4:175626197-175626198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs181397244 | chr4:175626202-175626203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs146138111 | chr4:175626225-175626226 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs35754169 | chr4:175626243-175626244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs115300172 | chr4:175626301-175626302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549775630 | chr4:175626421-175626422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7689256 | chr4:175626441-175626442 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs538775631 | chr4:175626442-175626443 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78700918 | chr4:175626454-175626455 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs7684257 | chr4:175626456-175626457 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs572185197 | chr4:175626464-175626465 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375822902 | chr4:175626530-175626531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs534772725 | chr4:175626632-175626633 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554567867 | chr4:175626637-175626638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs539285371 | chr4:175626671-175626672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs73867682 | chr4:175626733-175626734 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs553816149 | chr4:175626755-175626756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149239365 | chr4:175626818-175626819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13118343 | chr4:175626866-175626867 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs185487160 | chr4:175626880-175626881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs75188175 | chr4:175626935-175626936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs545220860 | chr4:175626952-175626953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565370985 | chr4:175626991-175626992 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs531257409 | chr4:175626993-175626994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs147178082 | chr4:175626997-175626998 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190001528 | chr4:175627017-175627018 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547923433 | chr4:175627090-175627091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs575678854 | chr4:175627173-175627174 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs561448031 | chr4:175627183-175627184 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140179969 | chr4:175627196-175627197 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547824648 | chr4:175627198-175627199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs373767095 | chr4:175627207-175627208 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550482302 | chr4:175627223-175627224 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs376725255 | chr4:175627237-175627238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs149255509 | chr4:175627238-175627239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs551993370 | chr4:175627241-175627242 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565719884 | chr4:175627242-175627243 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs534536929 | chr4:175627243-175627244 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs554714201 | chr4:175627244-175627245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567898608 | chr4:175627247-175627248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs547759815 | chr4:175627249-175627250 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574895900 | chr4:175627250-175627251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs372286444 | chr4:175627254-175627255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs375282755 | chr4:175627275-175627276 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs576069401 | chr4:175627279-175627280 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs572391524 | chr4:175627285-175627286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182260264 | chr4:175627297-175627298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Cancer | 20164919 | CNVD |
Prostate cancer | 22341455 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:175624600-175628400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr4:175628000-175629200 | Enhancers | Fetal Kidney | kidney |
3 | chr4:175628200-175630600 | Enhancers | A549 | lung |
4 | chr4:175628400-175631600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr4:175629000-175631600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr4:175630400-175631800 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr4:175630600-175631600 | Flanking Active TSS | A549 | lung |
8 | chr4:175631600-175632200 | Active TSS | A549 | lung |
9 | chr4:175631600-175634400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |